Long-Term Effects of Unmodified 50 nm ZnO in Mice
- 108 Downloads
Nanometer zinc oxide (nano-ZnO) is widely used in many kinds of fields. However, information about the toxicity and toxic mechanism of nano-ZnO is limited. The aims of this study were to investigate the long-term toxic effects of unmodified 50 nm ZnO administered by gavage in mice. After 90 days, hematological parameters, hepatic and renal functions, and oxidative and anti-oxidative status were measured. Pathological damages in livers, kidneys, and other tissues were also examined by hematoxylin and eosin (H&E) staining. The results showed that oral nano-ZnO exposure induced anemia and damages to liver and kidney, influenced the antioxidant system, and impacted functions of liver and kidney in mice after a 90-day exposure. The main cause for oxidative stress in vivo induced by nano-ZnO might be hydroxyl free radical. The lowest observed adverse effect level (LOAEL) was 40 mg/kg·bw, and the livers, kidneys, lungs, pancreas, and gastrointestinal tracts are the target organs.
KeywordsNanometer zinc oxide Sub-chronic toxicity LOAEL Target organs
This work was supported by the National Natural Science Foundation of China (Nos. 31402263 and 41301562) and China Scholarship Council (Grant No. 201608410282).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 3.Ben-Slama I, Amara S, Mrad I, Rihane N, Omri K, Mir EL, Ghoul JEL et al (2015) Sub-acute oral toxicity of zinc oxide nanoparticles in male rats. J Nanomed Nanotechnol 6(3):100284–100289Google Scholar
- 18.Kaya H, Aydin F, Gürkan M, Yilmaz S, Ates M, Demir V et al (2016) A comparative toxicity study between small and large size zinc oxide nanoparticles in tilapia (Oreochromisniloticus): organ pathologies, osmoregulatory responses and immunological parameters. Chemosphere 144:571–582CrossRefGoogle Scholar
- 20.Kim CS, Nguyen HD, Ignacio RM, Kim JH, Cho YC, Maeng EH et al (2014a) Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge. Int J Nanomedicine 9(Suppl 2):195–205Google Scholar
- 21.Kim YR, Park J, Lee EJ, Park SH, Seong NW, Kim JH (2014b) Toxicity of 100 nm zinc oxide nanoparticles: a report of 90-day repeated oral administration in Sprague Dawley rats. Int J Nanomedicine 9(Suppl 2):109–126Google Scholar
- 22.Lee CM, Jeong HJ, Yun KN, Kim DW, Sohn MH, Lee JK, Jeong J, Lim ST (2012) Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure. Int J Nanomedicine 7:3203–3209Google Scholar
- 30.Nriagu J (2011) Zinc toxicity in humans. Encycl Environ Health 801–807Google Scholar
- 33.Park HS, Shin SS, Meang EH, Hong JS, Park J, Kim SH et al (2014) A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats. Int J Nanomedicine 9(Suppl 2):79–92Google Scholar
- 37.Ryu HJ, Seo MY, Jung SK, Maeng EH, Lee SY, Jang DH et al (2014) Zinc oxide nanoparticles: a 90-day repeated-dose dermal toxicity study in rats. Int J Nanomedicine 9(Suppl 2):137–144Google Scholar
- 38.Seok SH, Cho WS, Park JS, Na Y, Jang A, Kim H, Cho Y, Kim T, You JR, Ko S, Kang BC, Lee JK, Jeong J, Che JH (2013) Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions. J Appl Toxicol 33(10):1089–1096CrossRefGoogle Scholar
- 40.Shalini D, Senthilkumar S, Rajaguru P (2017) Effect of size and shape on toxicity of zinc oxide (ZnO) nanomaterials in human peripheral blood lymphocytes. Toxicol Mech Methods 13:1–28Google Scholar
- 41.Sharma AK, Singh V, Gera R, Purohit MP, Ghosh D (2016) Zinc oxide nanoparticle induces microglial death by NADPH-oxidase-independent reactive oxygen species as well as energy depletion. Mol Neurobiol:1–14Google Scholar
- 45.Tiwari BK, Pandey KB, Abidi AB, Rizvi SI (2013) Markers of oxidative stress during diabetes mellitus. J Biomarkers 378790Google Scholar